TorreyPines Delays its Dissolution   What if a company called a
special shareholder meeting and nobody voted? Executives at San
Diego’s TorreyPines Therapeutics pondered the question today
after failing to muster enough votes for a proposal to liquidate
and dissolve the company. In a statement, TorreyPines said 62
percent of the biotech’s stockholders failed to vote on the
issue, which the board unanimously approved in May. The measure
to dissolve the company requires a majority of outstanding
voting shares for approval. In a bid to collect enough votes,
TorreyPines adjourned its meeting until July 16th at the
company’s corporate offices.